History & Overview Annual Report President's Pages Center News Community Affairs

Make a Gift Yankees Universe Fund Fred's Team Donating Blood & Platelets Volunteering Thrift Shop Park Avenue Potluck Cookbook

Press Releases Information for Journalists News@MSKCC

Manhattan New Jersey Long Island Westchester

Working at Memorial Sloan-Kettering Work Sites College Recruitment About Nursing Job Fairs & Career Days Job Search & Apply Online

Clinical Trials

Clicking a link below will scroll the
page down to the relevant section

Bladder Cancer
Germ Cell Tumors
Kidney Cancer
Prostate Cancer

A Phase II Study of Docetaxel with or without Zactima (ZD6474) in Metastatic Transitional Cell Carcinoma
Bajorin, Dean, MD

[Protocol 07-076]
A Phase II Study of Sunitinib in Metastatic Transitional Cell Carcinoma of the Urothelium
Bajorin, Dean, MD

[Protocol 06-081]
A Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy-naïve Patients with Advanced/Metastatic Urothelial Carcinoma
Bajorin, Dean, MD

[Protocol 06-006]
A Phase III Study of Mycobacterial Cell Wall-DNA Complex for Patients with Superficial Bladder Cancer at High Risk of Progression Who Are Refractory to Bacillus Calmette-Guerin
Herr, Harry, MD

[Protocol 07-016]
A Prospective Study of Quality of Life in Patients Undergoing Pelvic Exenteration
Chi, Dennis, MD

[Protocol 05-001]
A Survey of Penile Injection Anxiety
Nelson, Christian, PhD

[Protocol 07-001]

Germ Cell Tumors

A Phase I Trial of Sequential Paclitaxel/Ifosfamide and Dose-Intensive Paclitaxel, Carboplatin, and Dose-Escalated Ifosfamide with Stem Cell Support in Cisplatin- Resistant Germ Cell Tumor Patients
Motzer, Robert, MD

[Protocol 06-077]
A Phase II Study of Sunitinib in Patients with Refractory or Relapsed Germ Cell Tumors
Motzer, Robert, MD

[Protocol 07-004]
Phase II Trial of Paclitaxel, Ifosfamide, and Cisplatin in Patients with Previously Untreated Advanced Germ Cell Tumors
Motzer, Robert, MD

[Protocol 07-044]

A Phase I Study of RAD001 and Sunitinib in Patients with Metastatic Renal Cell Carcinoma
Kroog, Glenn, MD

[Protocol 06-105]
A Phase I Study of Yttrium-90 Attached to Chimeric Monoclonal Antibody CG250 in Patients with Advanced Renal Cancer
Larson, Steven, MD

[Protocol 05-031]
A Phase II Study of Sunitinib (Sutent^®) in Patients with Renal Cell Carcinoma or Melanoma that Has Spread to the Brain
Abrey, Lauren, MD

[Protocol 07-009]
A Phase III Study of Adjuvant Sunitinib versus Placebo in Patients with High-Risk Renal Cell Carcinoma
Motzer, Robert, MD

[Protocol 07-086]
A Phase III Study of Sunitinib Alone or in Combination with Interferon Alfa-2B as First-Line Therapy for Metastatic Renal Cell Cancer (Renal EFFECT Trial)
Motzer, Robert, MD

[Protocol 05-124]
A Study of Temsirolimus and Sorafenib as Second-Line Therapy in Patients with Advanced Renal Cell Carcinoma that Has Grown Despite First-Line Sunitinib Therapy
Motzer, Robert, MD

[Protocol 07-124]
Phase II Study of Sunitinib in Patients with Metastatic Papillary Renal Cell Carcinoma
Kroog, Glenn, MD

[Protocol 07-019]

Prostate Cancer

2-[¹⁸F]-Deoxy-D-Glucose (FDG) and [¹⁸F] Dihydro-Testosterone PET Imaging in Patients with Progressive Prostate Cancer
Morris, Michael, MD

[Protocol 00-095]
A Phase I Dose-Escalation Study of BMS-641988 in Patients with Castration-Resistant Prostate Cancer
Scher, Howard, MD

[Protocol 06-030]
A Phase I Study of MDV3100 in Patients with Castration-Resistant Prostate Cancer
Scher, Howard, MD

[Protocol 07-045]
A Phase I Study of MK-4721 in Patients with Advanced Hormone-Refractory Prostate Cancer
Morris, Michael, MD

[Protocol 08-004]
A Phase I Trial of PCK3145 in Patients with Asymptomatic, Castrate Metastatic Prostate Cancer
Slovin, Susan, MD, PhD

[Protocol 05-019]
A Phase I/II Study of MDX-010 in Patients with Metastatic Hormone-Refractory Prostate Cancer
Slovin, Susan, MD, PhD

[Protocol 05-067]
A Phase I/II Trial of Samarium (Sm-153) Lexidronam Combined with Docetaxel for Patients with Androgen-Independent Prostate Cancer
Morris, Michael, MD

[Protocol 05-014]
A Phase II Study of EMD121974 (Cilengitide) in Patients with Non-Metastatic Androgen-Independent Prostate Cancer
Slovin, Susan, MD, PhD

[Protocol 06-083]
A Phase II Study of Panobinostat (LBH589) in Patients with Metastatic Hormone-Refractory Prostate Cancer
Rathkopf, Dana, MD, PhD

[Protocol 08-013]
A Phase II Study of Preoperative Lycopene Supplementation in Prostate Cancer Patients
Eastham, James, MD

[Protocol 06-118]
A Phase III Study of Androgen Deprivation with Leuprolide with or without Docetaxel for Clinically Asymptomatic Prostate Cancer Patients with a Rising PSA Following Surgery
Morris, Michael, MD

[Protocol 07-101]
A Phase III Study of Early Versus Standard Zoledronic Acid to Prevent Bone Problems in Men with Prostate Cancer that Has Spread to the Bone
Morris, Michael, MD

[Protocol 06-091]
A Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
Eastham, James, MD

[Protocol 07-041]
A Phase III Trial Comparing Docetaxel and Prednisone with and without Bevacizumab in Men with Hormone-Refractory Prostate Cancer
Morris, Michael, MD

[Protocol 05-078]
A Phase Ib Study of Panobinostat (LBH589) with Docetaxel and Prednisone in Patients with Hormone-Refractory Prostate Cancer
Rathkopf, Dana, MD, PhD

[Protocol 07-163]
A Pilot Study of High Dose-Rate Prostate Brachytherapy as Salvage Therapy for Locally Recurrent Prostate Cancer Previously Treated with External Beam Radiotherapy
Yamada, Yoshiya, MD

[Protocol 06-122]
A Pilot Study of High-Dose Rate Brachytherapy as Definitive Management for Intermediate Risk Prostate Cancer
Yamada, Yoshiya, MD

[Protocol 07-120]
A Survey of Penile Injection Anxiety
Nelson, Christian, PhD

[Protocol 07-001]
Assessing Depression in a Geriatric Cancer Population
Nelson, Christian, PhD

[Protocol 06-100]
Clinical Significance of Germline BRCA Mutations
Offit, Kenneth, MD

[Protocol 96-051]
High Intensity Focused Ultrasound for the Treatment of Low-Risk, Localized Prostate Cancer
Eastham, James, MD

[Protocol 08-016]
Longitudinal Assessment of Health-Related Quality of Life in Men with Localized Prostate Cancer
Scardino, Peter, MD

[Protocol 02-042]
Neoadjuvant Hormonal Therapy in Combination with Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer
Slovin, Susan, MD, PhD

[Protocol 06-160]
Prospective Assessment of Clinical and Quality of Life Outcomes After Open or Laparoscopic Radical Prostatectomy
Eastham, James, MD

[Protocol 04-094]
Radiotherapy Plus Sildenafil (Viagra) to Preserve Erectile Function Versus Radiotherapy Alone in Localized Prostate Cancer
Zelefsky, Michael, MD

[Protocol 05-007]
Serum Protein Profiling to Characterize Patient Risk in Men Undergoing Radical Prostatectomy
Eastham, James, MD

[Protocol 04-132]
The Impact of Androgen Ablation Therapy on Cognitive Functioning and Functional Status in Men with Prostate Cancer Age 65 and Older
Nelson, Christian, PhD

[Protocol 06-084]

Germ Cell

A Phase I Trial of Sequential Paclitaxel/Ifosfamide and Dose-Intensive Paclitaxel, Carboplatin, and Dose-Escalated Ifosfamide with Stem Cell Support in Cisplatin- Resistant Germ Cell Tumor Patients
Motzer, Robert, MD

[Protocol 06-077]
A Phase II Study of Sunitinib in Patients with Refractory or Relapsed Germ Cell Tumors
Motzer, Robert, MD

[Protocol 07-004]
Phase II Trial of Paclitaxel, Ifosfamide, and Cisplatin in Patients with Previously Untreated Advanced Germ Cell Tumors
Motzer, Robert, MD

[Protocol 07-044]

Site Map \| Index	Legal Disclaimer \| Privacy Practices \| Public Notices

©2008 Memorial Sloan-Kettering Cancer Center. 212-639-2000 1275 York Avenue New York, NY 10065.	PublicAffairs@mskcc.org